Total Payments
$2.1M
2024 Payments
$156,721
Companies
20
Transactions
2,324
Payment Breakdown by Category
Other$1.7M (79.2%)
Consulting$267,814 (12.7%)
Travel$130,955 (6.2%)
Food & Beverage$38,039 (1.8%)
Research$1,280 (0.1%)
Education$437.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.5M | 715 | 71.2% |
| Consulting Fee | $267,814 | 115 | 12.7% |
| Honoraria | $165,518 | 56 | 7.9% |
| Travel and Lodging | $130,955 | 667 | 6.2% |
| Food and Beverage | $38,039 | 761 | 1.8% |
| Grant | $3,210 | 3 | 0.2% |
| Unspecified | $1,280 | 2 | 0.1% |
| Education | $437.00 | 5 | 0.0% |
Payments by Type
General
$2.1M
2,322 transactions
Research
$1,280
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $413,957 | 447 | $0 (2022) |
| Amgen Inc. | $336,766 | 382 | $0 (2022) |
| ABBVIE INC. | $324,582 | 301 | $0 (2024) |
| Lilly USA, LLC | $291,353 | 424 | $0 (2024) |
| Lundbeck LLC | $194,036 | 222 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $129,022 | 134 | $0 (2022) |
| Biohaven Pharmaceuticals, Inc. | $109,256 | 91 | $0 (2021) |
| IMPEL PHARMACEUTICALS INC. | $91,858 | 67 | $0 (2023) |
| Biohaven Pharmaceutical Holding Company Ltd. | $70,440 | 64 | $0 (2022) |
| Promius Pharma LLC | $47,054 | 47 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $156,721 | 162 | ABBVIE INC. ($100,013) |
| 2023 | $158,470 | 175 | Lundbeck LLC ($74,378) |
| 2022 | $332,818 | 308 | ABBVIE INC. ($100,479) |
| 2021 | $440,231 | 387 | Biohaven Pharmaceuticals, Inc. ($102,724) |
| 2020 | $339,097 | 344 | Allergan, Inc. ($145,541) |
| 2019 | $344,530 | 493 | Allergan Inc. ($110,686) |
| 2018 | $229,070 | 299 | Amgen Inc. ($77,417) |
| 2017 | $104,693 | 156 | Allergan Inc. ($26,055) |
All Payment Transactions
2,324 individual payment records from CMS Open Payments — Page 1 of 93
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $31.57 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/20/2024 | ABBVIE INC. | BOTOX (Biological) | Consulting Fee | Cash or cash equivalent | $2,600.00 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/15/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,250.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $97.55 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | Lundbeck LLC | VYEPTI (Biological) | Honoraria | Cash or cash equivalent | $3,680.00 | General |
| Category: NEUROLOGY | ||||||
| 10/30/2024 | Lundbeck LLC | VYEPTI (Biological) | Consulting Fee | Cash or cash equivalent | $3,220.00 | General |
| Category: NEUROLOGY | ||||||
| 10/30/2024 | Lundbeck LLC | VYEPTI (Biological) | Travel and Lodging | Cash or cash equivalent | $241.20 | General |
| Category: NEUROLOGY | ||||||
| 10/19/2024 | Lundbeck LLC | VYEPTI (Biological) | Consulting Fee | Cash or cash equivalent | $50.00 | General |
| Category: NEUROLOGY | ||||||
| 10/19/2024 | Lundbeck LLC | VYEPTI (Biological) | Consulting Fee | Cash or cash equivalent | $50.00 | General |
| Category: NEUROLOGY | ||||||
| 10/19/2024 | Lundbeck LLC | VYEPTI (Biological) | Consulting Fee | Cash or cash equivalent | $36.63 | General |
| Category: NEUROLOGY | ||||||
| 10/19/2024 | Lundbeck LLC | VYEPTI (Biological) | Consulting Fee | Cash or cash equivalent | $25.00 | General |
| Category: NEUROLOGY | ||||||
| 10/18/2024 | Lundbeck LLC | VYEPTI (Biological) | Consulting Fee | Cash or cash equivalent | $653.95 | General |
| Category: NEUROLOGY | ||||||
| 10/18/2024 | Lundbeck LLC | VYEPTI (Biological) | Consulting Fee | Cash or cash equivalent | $238.26 | General |
| Category: NEUROLOGY | ||||||
| 10/18/2024 | Lundbeck LLC | VYEPTI (Biological) | Travel and Lodging | Cash or cash equivalent | $202.53 | General |
| Category: NEUROLOGY | ||||||
| 10/18/2024 | Lundbeck LLC | VYEPTI (Biological) | Consulting Fee | Cash or cash equivalent | $124.99 | General |
| Category: NEUROLOGY | ||||||
| 10/17/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $71.43 | General |
| Category: NEUROLOGY | ||||||
| 10/17/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $53.57 | General |
| Category: NEUROLOGY | ||||||
| 10/01/2024 | Lundbeck LLC | VYEPTI (Biological) | Honoraria | Cash or cash equivalent | $3,680.00 | General |
| Category: NEUROLOGY | ||||||
| 10/01/2024 | Lundbeck LLC | VYEPTI (Biological) | Travel and Lodging | Cash or cash equivalent | $469.00 | General |
| Category: NEUROLOGY | ||||||
| 09/21/2024 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Neuroscience | ||||||
| 09/20/2024 | Lundbeck LLC | VYEPTI (Biological) | Consulting Fee | Cash or cash equivalent | $60.00 | General |
| Category: NEUROLOGY | ||||||
| 09/17/2024 | Lundbeck LLC | VYEPTI (Biological) | Travel and Lodging | Cash or cash equivalent | $210.28 | General |
| Category: NEUROLOGY | ||||||
| 09/16/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $124.98 | General |
| Category: NEUROLOGY | ||||||
| 08/13/2024 | Lundbeck LLC | VYEPTI (Biological) | Honoraria | Cash or cash equivalent | $2,760.00 | General |
| Category: NEUROLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A MULTICENTER, RANDOMIZED, OPEN LABEL EXTENSION STUDY TO EVALUATE THE LONG TERM SAFETY AND TOLOERABILITY OF ORAL UBROGEPANT IN THE ACUTE TREATMENT OF MIGRANE WITH R WITHOUT AURA | Allergan Inc. | $660.00 | 1 |
| A PHASE 3 MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED SINGLE ATTACK STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF ORAL UBROGEPANT IN THE ACUTE TREATMENT OF MIGRAINE | Allergan Inc. | $620.00 | 1 |
About Dr. Stephen Landy, MD
Dr. Stephen Landy, MD is a Neurology healthcare provider based in Tupelo, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1528029618.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Landy, MD has received a total of $2.1M in payments from pharmaceutical and medical device companies, with $156,721 received in 2024. These payments were reported across 2,324 transactions from 20 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1.5M).
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location Tupelo, MS
- Active Since 03/29/2006
- Last Updated 04/14/2020
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1528029618
Products in Payments
- BOTOX (Biological) $282,370
- Aimovig (Biological) $272,272
- UBRELVY (Drug) $258,794
- VYEPTI (Biological) $194,036
- NURTEC ODT (Drug) $179,712
- EMGALITY (Drug) $161,097
- BOTOX (Drug) $100,562
- Trudhesa (Drug) $91,858
- REYVOW (Drug) $75,405
- QULIPTA (Drug) $73,415
- AJOVY (Drug) $72,802
- AJOVY (Biological) $45,316
- Zembrace (Drug) $40,399
- TROKENDI XR (Drug) $36,816
- ONZETRA Xsail (Drug) $23,850
- Cambia (Drug) $22,140
- ELYXYB - CELECOXIB (Drug) $9,161
- TEV-48125 (Biological) $6,582
- BOTOX - MIGRAINE (Drug) $5,178
- BOTOX CHRONIC MIGRAINE (Drug) $3,768
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Tupelo
Justin Graff, M.d, M.D
Neurology — Payments: $151,057
Neurology $151,057
Mark Fletcher, M.d, M.D
Neurology — Payments: $83,368
Neurology $83,368
Samuel Newell, M.d, M.D
Neurology — Payments: $11,419
Neurology $11,419
Donna Harrington, M.d, M.D
Neurology — Payments: $8,705
Neurology $8,705
William Oakes, M.d, M.D
Neurology — Payments: $5,618
Neurology $5,618
Esther Fischer, M.d, M.D
Neurology — Payments: $2,084
Neurology $2,084